Teladoc Health (NYSE:TDOC) PT Lowered to $10.00 at Piper Sandler

Teladoc Health (NYSE:TDOC) had its price target reduced by Piper Sandler from $25.00 to $10.00 in a report published on Tuesday, Benzinga reports. They currently have an overweight rating on the health services provider’s stock.

A number of other equities research analysts also recently issued reports on TDOC. Canaccord Genuity Group reduced their price objective on shares of Teladoc Health from $25.00 to $17.00 and set a buy rating for the company in a research report on Thursday, August 1st. Oppenheimer reduced their target price on shares of Teladoc Health from $21.00 to $17.00 and set an outperform rating for the company in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a hold rating for the company in a research report on Friday, August 2nd. Evercore ISI reduced their target price on shares of Teladoc Health from $14.00 to $10.00 and set an in-line rating for the company in a research report on Tuesday, July 9th. Finally, TD Cowen reduced their target price on shares of Teladoc Health from $15.00 to $9.00 and set a hold rating for the company in a research report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of Hold and an average price target of $13.56.

Teladoc Health Trading Up 0.8 %

NYSE:TDOC opened at $7.22 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The firm has a 50-day moving average of $9.57 and a 200-day moving average of $13.34. The company has a market cap of $1.24 billion, a PE ratio of -5.12 and a beta of 0.93. Teladoc Health has a one year low of $7.14 and a one year high of $25.84.

Insiders Place Their Bets

In other news, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now directly owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now directly owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CMO Stephany Verstraete sold 15,000 shares of Teladoc Health stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $7.60, for a total transaction of $114,000.00. Following the transaction, the chief marketing officer now directly owns 45,158 shares of the company’s stock, valued at $343,200.80. The disclosure for this sale can be found here. Insiders have sold a total of 52,714 shares of company stock valued at $472,714 in the last quarter. Insiders own 0.95% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. ICA Group Wealth Management LLC purchased a new position in Teladoc Health during the 4th quarter valued at about $28,000. Hexagon Capital Partners LLC raised its holdings in Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after buying an additional 1,065 shares during the last quarter. RIA Advisory Group LLC purchased a new position in Teladoc Health in the fourth quarter worth about $36,000. GAMMA Investing LLC purchased a new position in Teladoc Health in the fourth quarter worth about $41,000. Finally, Principal Securities Inc. purchased a new position in Teladoc Health in the fourth quarter worth about $45,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.